Original Article

Outpatient crystalluria: prevalence, crystal types, and associations with comorbidities and urinary tract infections at a provincial hospital

Abstract

Background and Objectives: Crystalluria refers to the occurrence of crystals in urine resulting from urinary supersaturation, which disrupts the balance between factors that promote and those that inhibit crystal formation in urine. This study aimed to assess the prevalence of crystalluria, identify crystal types, determine associated comorbidities, and assess links with bacterial urinary tract infections in outpatients at Hassan II Hospital in Settat.
Materials and Methods: A retrospective study was conducted from January 2022 to May 2023 at Hassan II Hospital. Urine samples from patients suspected of urinary tract infections, who underwent cytobacteriological urine examinations, were analyzed.
Results: Among 1,025 urine samples, 22.04% showed crystalluria. The mean age of patients was 51.3 with a standard deviation of 18.1 years. The most common crystal types were calcium oxalate (46.4%), uric acid (23.5%), urates (15.1%) and struvite (9.3%). Comorbidities including, diabetes, kidney failure, prostatitis, and nephrotic syndrome was associated with urinary crystal formation. The prevalence of urinary tract infections in patients with urinary crystals was 10.6%. Struvite crystals were specifically associated with bacterial infections, especially with Proteus mirabilis, Escherichia coli, Citrobacter freundii, Citrobacter koseri, and Enterobacter cloacae.
Conclusion: Monitoring urinary crystals is essential for preventing the formation of kidney calculi and crystal-associated infections, especially in high-risk individuals.

1. Daudon M, Jungers P, Lacour B. Clinical value of crystalluria study. Ann Biol Clin (Paris) 2004; 62: 379-393.
2. Simhadri PK, Rout P, Leslie SW (2024). Urinary crystals identification and analysis. StatPearls. Treasure Island (FL): StatPearls. Available from: https://www.ncbi.nlm.nih.gov/books/NBK606103/
3. Daudon M. Crystalluria. Nephrol Ther 2015; 11: 174-190.
4. Wang Z, Zhang Y, Zhang J, Deng Q, Liang H. Recent advances on the mechanisms of kidney stone formation (Review). Int J Mol Med 2021; 48: 149.
5. Frochot V, Daudon M. Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi. Int J Surg 2016; 36: 624-632.
6. Fogazzi GB, Delanghe J. Microscopic examination of urine sediment: phase contrast versus bright field. Clin Chim Acta 2018; 487: 168-173.
7. Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int 2005; 67: 1934-1943.
8. Verdesca S, Fogazzi GB, Garigali G, Messa P, Daudon M. Crystalluria: prevalence, different types of crystals and the role of infrared spectroscopy. Clin Chem Lab Med 2011; 49: 515-520.
9. Gillams K, Juliebø-Jones P, Juliebø SØ, Somani BK. Gender differences in kidney stone disease (KSD): findings from a systematic review. Curr Urol Rep 2021; 22: 50.
10. Manish K, Leslie S (2023). Uric Acid Nephrolithiasis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls. https://pubmed.ncbi.nlm.nih.gov/32809561/
11. Chao CT, Wang J, Huang JW, Hung KY, Chien KL. Frailty predicts a higher risk of incident urolithiasis in 525,368 patients with diabetes mellitus: a population-based study. BMJ Open Diabetes Res Care 2020; 8(1): e000755.
12. Taguchi K, Okada A, Unno R, Hamamoto S, Yasui T. Macrophage function in calcium oxalate kidney stone formation: a systematic review of literature. Front Immunol 2021; 12: 673690.
13. Bichler KH, Eipper E, Naber K, Braun V, Zimmermann R, Lahme S. Urinary infection stones. Int J Antimicrob Agents 2002; 19: 488-498.
14. Karki N, Leslie SW (2023). Struvite and triple phosphate renal calculi. In: StatPearls [Internet]. Treasure Island (FL): StatPearls. https://pubmed.ncbi.nlm.nih.gov/33760542/
15. Schwaderer AL, Wolfe AJ. The association between bacteria and urinary stones. Ann Transl Med 2017; 5: 32.
16. Cavanaugh C, Perazella MA. Urine sediment examination in the diagnosis and management of kidney disease: core curriculum 2019. Am J Kidney Dis 2019; 73: 258-272.
17. Lee AJ, Yoo EH, Bae YC, Jung SB, Jeon CH. Differential identification of urine crystals with morphologic characteristics and solubility test. J Clin Lab Anal 2022; 36(11): e24707.
18. Asma Sakalli A, Küçükerdem HS, Aygün O. What is the relationship between serum uric acid level and insulin resistance? A case-control study. Medicine (Baltimore) 2023; 102(52): e36732.
19. Park JH, Jo YI, Lee JH. Renal effects of uric acid: hyperuricemia and hypouricemia. Korean J Intern Med 2020; 35: 1291-1304.
20. Xu Z, Yao X, Duan C, Liu H, Xu H. Metabolic changes in kidney stone disease. Front Immunol 2023; 14: 1142207.
21. Dessombz A, Méria P, Bazina D, Foy E, Rouzière S, Weil R, et al. Revisiting the chemical diversity in prostatic calculi: an SEM and FT-IR investigation. Prog Urol 2011; 21: 940-945.
Files
IssueVol 17 No 3 (2025) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijm.v17i3.18820
Keywords
Crystalluria Comorbidity Urinary tract infections Bacterial infections Kidney calculi
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Natoubi S, Jamal R, Baghdad N. Outpatient crystalluria: prevalence, crystal types, and associations with comorbidities and urinary tract infections at a provincial hospital. Iran J Microbiol. 2025;17(3):382-389.